Rayner Intraocular Lenses Limited (Rayner), the leading intraocular lens (IOL) pioneer has introduced *RaySert®, a small-incision IOL injector system. With a 1.8-mm diameter external tip, RaySert® enables surgeons to insert an IOL through a sub-2.5-mm incision, reducing surgically induced astigmatism.
Designed for use initially with the Rayner’s C-flex range of IOLs, RaySert® assures ease of use with controlled delivery through a convenient single-handed injection system. Surgeons can perform cataract surgery using truly small surgical incisions, using the RaySert®, to enhance patient comfort and recovery.
The basic premise of RaySert® is to enable the implantation of Rayner IOLs through the smallest possible incision size, thus guaranteeing the optimal relationship between IOL design and incision size. This is an important dynamic according to Mark Packer, MD: “The specific features of the IOL represent mountains in comparison to the molehills of the incision size. We often say, ‘The patient will never know – or care – if the lens went through a 2, 3 or 4-mm incision. The patient will care about the long-term quality of vision.’”
RaySert® was launched on April 11 at the ASCRS Symposium on Cataract, IOL, and Refractive Surgery in Boston. Leading ophthalmologists, Guy Kleinmann, MD; Ashok Vyas, MD; and Mark Packer, MD shared insightful information on their initial experiences with RaySert®. According to Mr Vyas, “IOL injections through small incisions need not compromise on lens design. RaySert® features a 1.8-mm tip, allowing delivery of the lens through an incision as small as 2.2 mm. However, since the parallel section length is 1.1 mm, surgeons can also position the tip inside the anterior chamber for lens delivery if they are comfortable with this technique.”
“As an innovator in IOL technology, the introduction of the RaySert® small-incision injector system is a natural progression, in delivering physicians with a new level of control and ease in IOL delivery. It is yet another milestone in Rayner’s commitment to optimize the accuracy and safety of IOL surgery outcomes,” says Donald J. Munro, Chairman and Managing Director, Rayner.
RaySert® is available for worldwide sales as a single-use injector.
*The RaySert® small-incision IOL injector system is currently available for sale in the US as R-INJ-04/18.
About Rayner
Rayner Intraocular Lenses Limited (Rayner), the pioneering intraocular lens (IOL) manufacturer has a 60-year legacy of dedication to improving vision and the restoration of sight worldwide. With an unrivalled history of commitment to the advancement of IOL technology, Rayner has the unique honour of manufacturing the world’s first IOL. Rayner is also the first and only IOL manufacturer to receive the Queen’s Award for Enterprise in International Trade.
Rayner’s injectable hydrophyllic IOLs are designed for both patient and practitioner ease and comfort, and are available in monofocal, multifocal, toric, supplementary and extended power range varieties. Headquartered in Hove, East Sussex, United Kingdom, Rayner markets its IOL products directly in the UK and worldwide, through a network of distributors.
